The influence of antenatal betamethasone timing on neonatal outcome in late preterm infants: a single-center cohort study
Archives of Gynecology and Obstetrics · 2024
DOI: 10.1007/s00404-024-07714-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Thomas Brückner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Paediatrics, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Sachsen-Anhalt, Germany. thomas.brueckner@charite.de. Hauptthemen laut MEDLINE: Betamethasone, Glucocorticoids, Premature Birth, Prenatal Care. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Otto-von-Guericke-Universität Magdeburg.
Themen: Neonatologie
Abstract (Originalsprache)
Purpose
Many pregnancies continue after antenatal corticosteroid exposure. Since long-term effects on late preterm neonatal outcome remain controversial, it remains unknown whether pregnant women who are at risk for preterm birth during the late preterm period and had prior antenatal corticosteroid exposure would benefit from an additional course of antenatal corticosteroids. We evaluated the need for future trials on this topic by comparing short term effects from antenatal betamethasone to long-term effects. We also examined the value of a risk-adapted approach.
Methods
We observed neonatal outcomes in late preterm infants (34/0–36/0 weeks of gestation) who were exposed to antenatal betamethasone either up to 10 days prior birth ( n = 8) or earlier in pregnancy ( n = 89). We examined a real world population from the University Hospital Magdeburg (Germany) between 01 January 2012 and 31 December 2018, and a simulated high-risk population that was derived from the original data.
Results
The indicators for relevant adverse outcomes did not differ in the unselected population. In the simulated high-risk population, recent antenatal corticosteroid administration significantly reduced the incidence of relevant cardiorespiratory morbidities (OR = 0.00, p = 0.008), and reduced the number needed to treat from 3.7 to 1.5.
Conclusion
The superiority of recent antenatal corticosteroid administration in the late preterm period over earlier exposure strongly depended on the prevalence of respiratory disease. Before considering clinical trials on additional antenatal corticosteroid courses in the late preterm period, antenatal assessment tools to predict respiratory morbidity need to be developed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paediatrics, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Sachsen-Anhalt, Germany. thomas.brueckner@charite.de.
- Charité - Universitätsmedizin Berlin, SPZ-Neuropädiatrie, Augustenburger Platz 1, Campus: Ostring 1, 13353, Berlin, Germany. thomas.brueckner@charite.de.
- University Hospital for Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Gerhart-Hauptmann Straße 35, 39108, Magdeburg, Sachsen-Anhalt, Germany.
ORCID-Profile: Thomas Brückner, Anke Redlich
Förderung
- Otto-von-Guericke-Universität Magdeburg
Zitieren
APA
Brückner, T., & Redlich, A. (2024). The influence of antenatal betamethasone timing on neonatal outcome in late preterm infants: a single-center cohort study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07714-9
Vancouver
Brückner T, Redlich A. The influence of antenatal betamethasone timing on neonatal outcome in late preterm infants: a single-center cohort study. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07714-9
BibTeX
@article{Brckner2024,
author = {Brückner, Thomas and Redlich, Anke},
title = {The influence of antenatal betamethasone timing on neonatal outcome in late preterm infants: a single-center cohort study},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
doi = {10.1007/s00404-024-07714-9}
}
EUVIMED